Ligand profile
3X3
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_04919 — 3-oxoacyl-[acyl-carrier-protein] reductase
Identifiers
Database identifiers and provenance.
- Ligand ID
3X3- PDB
4bo9- UniProt (similar protein)
O54438- Target protein
- KP13_04919
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 66.0
- −1 ≤ LogP ≤ 5 3.50
- MW ≤ 500 Da 318.3
- LogP ≤ 5 3.50
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 66.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1ccc(cc1)n2nc(nn2)c3ccccc3OCc4ccco4c1ccc(cc1)n2nc(nn2)c3ccccc3OCc4ccco4
InChI=1S/C18H14N4O2/c1-2-7-14(8-3-1)22-20-18(19-21-22)16-10-4-5-11-17(16)24-13-15-9-6-12-23-15/h1-12H,13H2InChI=1S/C18H14N4O2/c1-2-7-14(8-3-1)22-20-18(19-21-22)16-10-4-5-11-17(16)24-13-15-9-6-12-23-15/h1-12H,13H2
SEBHGPQMDPTLAQ-UHFFFAOYSA-NSEBHGPQMDPTLAQ-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF13561
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 3X3 →
- PDB RCSB structure 4bo9 →
- UniProt UniProt O54438 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “3X3”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_04919.
PDB 17
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 5
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).